StonvexLoading…
StonvexStonvexStonvexCore line items from SWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $3.85B | $15.13B | $11.45B | $7.69B |
Operating Income | $84.80M | $417.90M | $189.90M | $154.30M |
Net Income | $59.60M | $401.90M | $243.70M | $101.90M |
EPS (Diluted) | $0.39 | $2.65 | $1.61 | $1.27 |
Total Assets | $21.60B | $21.24B | $21.75B | $22.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $333.70M | $280.10M | $268.30M | $311.80M |
Free Cash Flow OCF − CapEx | $-447.30M | $687.90M | $-195.00M | $-350.30M |
Shares Outstanding | 152.39M | 155.04M | 151.80M | 151.71M |